Effectiveness During 12-Month Adjunctive Brivaracetam Treatment in Patients with Focal-Onset Seizures in a Real-Life Setting: A Prospective, Observational Study in Europe

Effectiveness During 12-Month Adjunctive Brivaracetam Treatment in Patients with Focal-Onset Seizures in a Real-Life Setting: A Prospective, Observational Study in Europe

Abstract Introduction Efficacy/tolerability of adjunctive brivaracetam (BRV) for focal-onset seizures (FOS) in patients aged ≥ 16 years was established in randomized controlled trials. This study aimed to evaluate the effectiveness of adjunctive BRV in patients (≥ 16 years) with FOS with/without foc...

Full description

Saved in:
Bibliographic Details
Main Authors: Bernhard J. Steinhoff, Jakob Christensen, Colin P. Doherty, Marian Majoie, Anne-Liv Schulz, Fiona Brock, Dimitrios Bourikas, Iryna Leunikava, Anna Kelemen, Eduardo Rubio-Nazabal
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-02-01
Series:Neurology and Therapy
Subjects:
Adjunctive
Adolescent
Brivaracetam
Effectiveness
Epilepsy
Focal-onset seizure
Online Access:https://doi.org/10.1007/s40120-024-00697-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40120-024-00697-4

Similar Items